Freestone Grove Partners’s Stoke Therapeutics STOK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,776	Closed	-$98.3K	–	845
2025 Q1	$98.3K	Sell	14,776 -3,273	-18%	-$21.8K	﹤0.01%	561
2024 Q4	$199K	Buy	+18,049	New	+$199K	﹤0.01%	534